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Abstract
The present study evaluated the long term hypoglycemic effect of Morus indica  L. in rats
induced with diabetes, to determine the changes in activity of glycolytic and gluconeogenic
enzymes and to compare the effect of Morus indica  L. with conventional antidiabetic drugs -
Insulin and Glibenclamide (OHA). Morus indica L. was obtained from the Department of Studies
in Sericulture, University of Mysore, India. The antihyperglycemic effect of the plant was tested
in streptozotocin induced diabetic rats. The effect of Morus indica L. on carbohydrate metabolizing
enzymes was also studied. Morus indica powder (MIP) at a level of 500mg/kg body weight,
reduced blood glucose level in the animals by 42% after 45 days. The blood glucose in animals
supplemented with MIP decreased from an initial level of 257± 69.4 to 148.8 ± 34.48 mg/dl. The
activity of aldolase in the liver of MIP and Insulin treated groups was 0.19u/g and in Glibenclamide
treated group, it was 0.18u/g protein. The activity of G-6-PDH decreased significantly (p<0.05)
in untreated diabetic group (0.24 ± 0.04 mIU/mg). The  G-6-PDH levels  in MIP, Insulin and
Glibenclamide treated group were  1.38 ± 0.48, 0.98 ± 0.10 and 1.04 ± 0.42 mIU/mg protein,
respectively which were higher compared to the diabetic control group. The activities of AsAT
and AlAT decreased significantly in animals treated with Morus, Insulin and Glibenclimide.  The
results prove that Morus could effectively reduce the blood glucose, total cholesterol, triglycerides
and also reverse the activity of elevated enzymes which can prove beneficial in the management
of hyperglycemia.
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1.  Introduction
Diabetes mellitus is the most severe metabolic pandemic of 21st
century, affecting essential biochemical activities in almost every
cell in the body and increasing the risk of cardiac problems (Gupta
et al., 2008). Diabetes is possibly the world’s fastest growing
metabolic disease; it is the third commonest disease in the world
next to the cardiovascular and oncological disorders according to
World Health Organization data (Srinivasan, 2005).
Though different types of oral hypoglycemic agents are available
along with insulin for the treatment of diabetes mellitus, there is
increasing demand by patients to use the natural products with
antidiabetic activity (Venkatesh, 2003). Clinical examinations have
demonstrated hypoglycemic and hypolipidemic activity in extracts
from many plants (Kelkar et al., 1996; Ragavan et al., 2006; Kumar
et al, 2005; Vasanthamani and Savitha, 2001; Chandrashekar et al.,
1989; Kaleem et al., 2006).
The relationship between diabetes and hyperlipedemia is a well-
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diabetes, contributing to the high prevalence of accelerated
atherosclerosis and coronary heart disease. Increase in plasma
triglycerides and very low density lipoproteins have been found in
diabetic patients (Andallu et al., 2001). Several studies have reported
increases in the concentration of lipid peroxides in the blood and
urine of diabetics, and also considerable changes in the structural
organization and functions of red blood cell membrane are seen
(Shukla et al., 2000).
Medicinal plants have an important role in modulating glycemic
responses and have preventive and therapeutic implications for
certain conditions such as diabetes, hyperlipedemia, etc. Many
Indian medicinal plants have been found to be useful in successfully
managing diabetes, significant among them are : Gymnema sylvestre,
Pterocarus marupium, Eugenia jambolana, Swertia chiraita,
Syzigium cumini, Momordica charantia, Fenugreek, T. arjuna, the
active principles have been isolated from some of them (Kaleem
et al., 2006; Shukla et al., 2000).
The hypoglycemic effect of Morus indica L. has been studied in
animal model wherein the plant in the dehydrated powder form
was supplemented at 25% level in the diet (Shukla et al., 2000).
This amount is practically not feasible for consumption, also there
are no detailed studies on the effects of Morus indica L. on the
biochemical parameters and activity of enzymes abnormally altered
due to diabetes mellitus. The results of a preliminary study wherein
Morus indica powder was supplemented at a level of 500mg/kg
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body weight reduced the blood glucose of diabetic rats (Vishalakshi
and Urooj, 2008). With this background, the present study was
planned to evaluate the long term hypoglycemic effect of Morus
indica L. in rats induced with diabetes. In addition, the changes in
activity of glycolytic and gluconeogenic enzymes was also
determined and compared with conventional antidiabetic drugs
Insulin and Glibenclamide (OHA).
2. Materials and Methods
2.1 Materials
Fresh Mulberry leaves (Morus indica L. MIP) were obtained from
the Department of Studies in Sericulture, University of Mysore,
India and subsequently identified by a botanist, DOS in Botany,
University of Mysore, Mysore. The leaves were washed, oven
dried (55-60°C), ground, passed through sieve and stored in airtight
container at refrigeration temperature before use.
Streptozotocin was procured from Sigma chemicals, Bangalore.
GOD-POD kit from Span Diagnostics (Surat, India). Glucose-6-
phosphate dehydrogenase (G-6-P) and Aldolase kits from Randox
Laboratories Ltd. Worli, Mumbai. Glutamic oxaloacetic transaminase
(AsAT) and Glutamic pyruvate transaminase (AlAT) kits from
Aggappe Diagnostics Ltd, Kerala. Total cholesterol, Triglycerides
kits from Coral clinical systems, Verna, Goa. Tris (hydroxymethyl)
aminomethane from SD Fine Chemicals, Bombay. All the other
chemicals used were of analytical grade and purchased locally.
Male albino rats (30) of Wister strain with body weights ranging
from 150-200g were procured from Central Animal House,
Department of Zoology, University of Mysore. The study was
approved by the Institutional Animal Ethics Committee, University
of Mysore (No.MGZ/578/2005-06). The animals were housed in
individual cages and were allowed to acclimatize for 15 days with
cereal-pulse based diet which consisted of wheat flour (62%),
defatted soya flour (18%), groundnut oil (10%), sugar (7%), vitamin
mix (1%) and mineral mix (2%) and water was provided ad libitum.
2.2 Experimental design
(a) The animals were divided into five groups (n=6) based on their
weights, using Randomized block design which is as follows:
Group I-Normal control (NC), Group II - Diabetic control (DC),
Group III-Diabetic group treated with  Morus indica (MIP),
Group IV-Diabetic group treated with Insulin (INS), Group V-
Diabetic group treated with Glibenclamide (GNB).
(b) Animals of group II, III, IV and V were rendered diabetic by a
single i.p injection of Streptozotocin (STZ) (55mg/kg b.wt)
(Andallu and Varadacharyulu, 2003) prepared in freshly
prepared 0.1M citrate buffer after an overnight fast. The diabetic
animals were provided 5% glucose solution for 24 h following
Streptozotocin injection to prevent initial drug-induced
hypoglycemic mortality. After 72 h of injection, blood was
drawn from Retro Orbital Plexus (RPO) of anaesthetized animal
which were fasted overnight to check the fasting blood glucose.
Rats with fasting blood glucose more than 250mg/dl were
selected for the experimental group with 6 animals in each
group.
(c) Morus indica powder at a level of 500mg/kg body weight was
mixed with the diet and provided to the animals of MIP group.
Animals of INS group were injected with insulin daily (5 units/
kg body weight), whereas, Glibenclimide was dissolved in
distilled water and fed orally (400g/kg body weight) daily to
the animals of GNB group (Sheela and Augusti, 1992). The
animals were maintained with above treatment for a period of
45 days. The weights of the animals were monitored weekly.
During the study period, daily food and water consumption
was determined and expressed as intake/week ± SD.
2.3 Blood collection
At the end of the study period, the animals were fasted for 12h,
anaesthetized (diethyl ether) and dissected, cardiac blood was
collected immediately into test tube and allowed to clot for 30min
at 2oC. The tubes were then centrifuged at 2500rpm for 20min in
cold condition (4oC). The serum was aspirated into ependorff tubes
and used for biochemical estimations. The liver was excised, washed
with saline and weighed, phosphate buffered saline (pH 7.4) was
added to liver 1:5 (w/v), and homogenized using Teflon pestle. The
homogenate was centrifuged at 2500rpm (5min); the supernatant
was used for the estimation of biochemical parameters.
2.4 Biochemical parameters
2.4.1  Blood glucose
Blood from tail vein of the overnight fasted rats was drawn weekly
and blood glucose was estimated immediately by Glucose-Oxidase
Peroxidase kit (Span- India) in protein free supernatant. The
threshold of urine sugar of the overnight fasted animals was
determined weekly using Uristix.
2.4.2 Estimation of G-6-P DH and aldolase activity
G-6-P DH and aldolase in the liver homogenate was estimated using
standard diagnostic kits (Randox).
2.4.3 Estimation of lipid peroxides
Lipid peroxides in the serum and liver homogenate were measured
according to the method of Ojhawa, Ohishi and Yagi (1979). The
lipid peroxidation products react with thiobarbituric acid forming a
pink coloured adduct on boiling which was measured.
2.4.4 Estimation of reduced glutathione
Reduced glutathione (GSH) in the serum and liver homogenate was
estimated based on the reaction of 5,5’dithiobis-2-nitrobenzoic acid
(DTNB) with compounds containing sulphydryl groups (Beutler,
Duron and Kelly, 1963).
2.4.5 Estimation of AsAT, AlAT, triglycerides and total cholesterol
AsAT, AlAT, Triglycerides and total cholesterol in the serum were
estimated at the end of the study period using standard kits
(Agappe).
2.5 Statistical analysis
Data were recorded as means ± standard deviation of duplicate
measurements and subjected to one-way-ANOVA using SPSS
software.
3.  Results
The effect of Morus indica L. on fasting blood glucose, carbohydrate
metabolizing enzymes (glucose-6-phosphate dehydrogenase and
aldolase), total cholesterol and triglycerides were studied in control
and streptozotocin induced diabetic rats.
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The changes in the body weights, food and water intake in normal
and diabetic rats are presented in Table 1. There was a significant
(p<0.05) decrease in body weights of the diabetic control group at
the end of the study period compared to other groups. The body
weights of the animals treated with MIP, INS and GNB decreased at
the end of first week, followed by a gradual increase ranging from
21-44% thereafter. In untreated diabetic rats, there was a significant
decrease (p<0.05) in the body weight (20%) compared to normal
rats. Oral administration of mulberry significantly increased the
body weight, although food and water intake increased during the
study period. It was significantly lower compared to diabetic
control group.
The food consumption pattern of the animals is given in Table 1.
The average weekly food intake was significantly low (p<0.05) in
the experimental groups (MIP- 42.9g, INS - 47.8 g and GNB - 51.5g)
compared to the healthy control group (67.8g), whereas the food
intake of untreated diabetic group (88.8g) was higher compared to
control group during the first week after induction of diabetes.
Food intake of the experimental group increased from second week
of the study period. The average weekly food intake of the treated
groups was significantly low compared to diabetic control group.
The average weekly water intake of the uncontrolled diabetic group
was significantly high compared to other groups (Table 1).
A significant reduction in blood glucose was seen following
treatment with M. indica powder from an initial level of 257± 69.4
to 148 ± 34.48 mg/dl at the end 45 days (p<0.05) (Table 2). A
gradual decrease in the blood glucose of the MIP group was observed
during the study period. After 6 weeks of treatment, the percent
reductions were 72, 64 and 42 in the three groups treated with
Insulin, Glibenclimide and MIP.
 The activities of G-6-PDH and Aldolase in the liver of control and
experimental rats are shown in Table 2. It was observed that the
activity of aldolase significantly increased in diabetic rats, when
compared with control rats (p<0.05). Oral administration of
M. indica powder for 45 days significantly reversed the values
which was almost comparable to control group. The activity of
aldolase in the liver of MIP was 0.19u/g Protein.
Serum cholesterol (TC) and triglyceride (TG) levels in all five groups
of animals are shown in Figure 1. The serum TC and TG levels were
significantly higher in diabetic rats compared to those in normal
rats. Treatment with MIP caused a significant reduction (p<0.05) in
both TC and TGL compared to INS and GNB group.
It was observed that the lipid peroxides in the liver homogenate of
MIP (0.22 ± 0.08Nm/mg P) was significantly low compared to DC
(0.43 ± 0.03 Nm/mg P), and was almost similar to that of GNB (0.21
± 0.04 nm/mg P). Serum MDA levels in the MIP group was 0.10 ±
0.03 nm/mg P which was significantly low compared to DC (0.29 ±
0.03 nm/mg P), INS (0.15 ± 0.02 nm/mg P) and GNB (0.21 ± 0.06
nm/mg P). Supplementation of Morus indica significantly increased
the GSH content (2.87 ± 1.72µm/mg P) which was significantly high
compared to DC (0.55 ± 0.10 µm/mg P) and GNB (1.07 ± 0.39µm/mg P)
whereas, the GSH content of INS group (3.91 ± 0.10 µm/mg P) was
significantly high compared to other experimental group. Serum
GSH in MIP group was significantly high (0.18 ± 0.05  µm/mg P)
compared to DC (0.05 ± 0.01 µm/mg P), whereas it was comparable
to INS (0.17 ± 0.03 µm/mg P) and GNB (0.17 ± 0.03 µm/mg P).
Induction of diabetes elevated the activity of AsAT and AlAT in the
animals, urea, creatinine and lipid peroxides, treatment with Morus
significantly (p<0.05) restored these parameters to near normal
levels in diabetic rats.
4. Discussion
In the present study, increased food and water consumption was
observed in the experimental groups in comparison to normal rats,
indicating polydypsia and loss of body weight due to excessive
breakdown of tissue proteins (Kameswararao et al., 2003). In an
earlier study also, it is reported that supplementation of M. indica
powder decreased the food intake and there was a gradual increase
in the body weights of the animals compared to control diabetic
group (Andallu and Varadacharyulu, 2003). Increase in the body
weights in the experimental groups may probably be due to the
improvement in insulin secretion and glycemic control. Similar
observations have been reported in the diabetic animals treated
with Ficus bengalensis  and Trigonella foenum greacum
(Kameswararao et al., 2003). Treatment with mulberry decreased
food consumption and improved body weight to some extent
indicating control over polyphagia and muscle wasting resulted due
to hyperglycemic condition. Data on blood glucose of the present
study indicates that MIP is effective in lowering the blood glucose
indicating the antihyperglycemic effect of Morus indica.
Liver acts as a “glucostat” and plays a vital role in the maintenance
of blood glucose level and, hence, it was of interest to examine the
possible role of Costus igneus on enzymes of carbohydrate
metabolism in liver. Aldolase, one of the key enzymes in the
glycolytic pathway, increases in diabetes and this may be due to
cell impairment and necrosis (Ragavan and Krishnakumari, 2006).
The higher activity of Glucose-6-phosphate dehydrogenase in the
liver of MIP group compared to untreated diabetic group suggests
the utilization of glucose by citric acid cycle and the pentose
pathway (Khan et al., 1995). The reduction in the blood glucose of
the experimental groups may be due to higher rate of glycolysis as
evidenced by the activity of aldolase and Glucose-6-phosphate
dehydrogenase, two of the key enzymes of Glycolysis (Ragavan
and Krishnakumari, 2006).
The activity of AsAT  and AlAT are cystolic marker enzymes
reflecting hepatocellular necrosis as they are released into the blood
after cell membrane damage. Therefore, we use the activities of
AsAT and AlAT in the circulation as indicators of hepatic damage
(Kim et al., 2006).  In the present study, treatment with Morus
effectively reduced serum AsAT and AlAT activities suggesting that
the plant could prevent hepatic injury associated with diabetes.
Many active compounds have been isolated from the plant and
herb species of India. These active principles are dietary fibers,
alkaloids, flavonoids, saponins, amino acids, steroids, peptides and
others. These have produced potent hypoglycemic, anti-
hyperglycemic, and glucose suppressive activities (Gupta et al.,
2008). The above effect of Morus may be due to insulin release
from pancreatic -cells, inhibited glucose absorption in gut,
stimulated glycogenesis in the liver or increased utilization by the
body (Grover et al., 2002). These compounds are also reported to
exhibit their antioxidant, hypolipidemic, restored enzymatic
functions, repair and regeneration of pancreatic islets and the
alleviation of liver and renal damage (Mukherjee et al., 2006). It is
reported that the compounds of mulberry leaves, particularly
fagomine, is capable of inducing insulin secretion in isolated rat
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Table 1: Changes in body weights, food and water consumption patterns of rats treated with Morus indica L.
Rat Body weight(g) Food intake (g) Water intake (ml)
group Init ia l 2nd wk 4 thwk 6th wk 1st wk 2nd wk 4th wk 6th wk 1st wk 2nd wk 4th wk 6th wk
N C 144 ± 184 ± 209 ± 231 ± 67.8 ± 68.7 ± 112.6 ± 138 ± 57.2 ± 72.5 ± 98.8 ± 118 ±
17.2 9.9 7.7 9.3 7.7 3.7 4.3 9.9 6.1 2.8 5.4 8.0
D C 192a ± 181a ± 161a ± 152a ± 88.8a ± 101.0a ± 136.4a ± 177a ± 93.4a ± 104.2a ± 145.6a ± 168a ±
7.5 6.5 7.3 5.5 6.5 2.5 8.2 6.5 7.2 8.3 7.5 5.8
MIP 156b ± 149b ± 173b ± 190b ± 42.9b ± 81.8b ± 128.9b ± 158b ± 43.4b ± 86.8b ± 136.5b ± 161b ±
13.4 10.2 11.4 30.4 2.5 3.7 10.5 13.9 2.5 2.7 3.4 4.8
INS 155b ± 179c ± 198c ± 224c ± 47.8c ± 73.4c ± 118.4c ± 151c ± 40.4c ± 75.3c ± 120.6c ± 148c ±
17.9 21.7 11.7 17.0 3.8 4.5 6.2 11.2 4.1 3.6 5.8 10.4
GN B 157b ± 168c ± 180d ± 204d ± 51.5d ± 80.2d ± 126.2d ± 162d ± 43.5b ± 83.0d ± 131.4d ± 158d ±
16.0 15.8 17.3 17.2 3.1 3.0 3.5 5.8 3.4 8.6 4.5 4.7
Mean values carrying superscripts a, b, c and d in columns differ significantly (p<0.05) between groups.
NC- Normal control, DC- Diabetic control, MIP – Morus indica leaves powder, INS-Insulin, GNB-Glibenclamide. (n=6 in each group)
Table 2: Blood glucose, glucose-6-phosphate dehydrogenase and aldolase levels of the animals
Rat Blood glucose (mg/dl) Enzymes (liver)
group Init ia l 2nd wk 4th wk 6th wk G-6-PDH (mIU/mg P) Aldolase (mIU/mg P)
N C 81 ± 11.3a 79 ± 5.24b 80 ± 7.03c 82 ± 3.61d
1.16 ± 0.28 0.16 ± 0.03
(1± 0.0) (1 ± 0.0) (1 ± 0.0) (1 ± 0.0)
D C 286 ± 25.0al 460 ± 63.7bl 473 ± 26.8cl 481 ± 25.11dl
0.54 ± 0.04a 0.24 ± 0.03a
(4 ± 0.001) (4 ± 0.001) (4 ± 0.001) (4 ± 0.001)
MIP 257.00 ± 69.41 am 158 ± 10.30bm 146 ± 12.16cm 148.8 ± 4.48dm
1.08 ± 0.48b 0.19 ± 0.07b
(4 ± 0.001) (1 ± 0.00) (1 ± 0.00) (1 ± 0.00)
INS 345 ± 57.44an 109 ± 6.29bn 101 ± 2.08cn 101 ± 1.91cn
0.98 ± 0.10c 0.19 ± 0.02b
(4 ± 0.001) (1 ± 0.00) (1 ± 0.0) (1 ± 0.0)
GN B 364 ± 34.52ao 149 ± 9.95bo 142 ± 5.75cm 123 ± 19.54do
1.04 ± 0.42b 0.18 ± 0.05b
(4 ± 0.001) (1 ± 0.00 ) (1 ± 0.0) (1 ± 0.0)
NC- Normal control, DC- Diabetic control, MIP – Morus indica leaves powder, INS-Insulin, GNB-Glibenclamide.  n= 6 in each group.
Mean values carrying superscripts a, b, c and d in rows within the group and l, m, n, o in columns between groups differ significantly (p<0.05)
Table 3: Biochemical parameters of the normal and streptozotocin induced diabetic animals
A ni ma l Liver homogenate Se r um
group MDA GS H MDA GS H AsAT AlAT Urea C r eat inine
(nm/mg P) (µm/mg P) (nm/mg ) (µm/mg P) (u/ml) (u/ml) (mg/dl) (mg/dl)
N C 0.05 ±  0.01 1.28 ± 0.26  0.08 ± 0.01 0.27 ±  0.26 53.3 ± 2.3 42.3 ± 1.51 23.03 ± 1.47 0.80 ± 0.07
D C 0.43 ± 0.03a 0.55 ± 0.10a 0.29 ± 0.03a 0.05 ± 0.01a 256.6 ±70.9 a 65.4 ± 19.1a 68.94 ± 7.03a 1.26 ± 0.17a
MIP 0.22 ± 0.08b 2.87 ± 1.72b 0.10 ± 0.03b 0.18 ± 0.05b 109.2 ± 26.1b 50.0 ± 16.0 42.8 ± 11.98b 0.78 ± 0.31
INS 0.16 ± 0.01c 3.91 ± 0.10c 0.15 ± 0.02c 0.17 ± 0.03b 96.3 ±  21.4c 47.6 ± 14.3c 42.58 ± 5.3b 0.84 ± 0.48c
GN B 0.21 ± 0.04b 1.07 ± 0.39d 0.21 ± 0.06b 0.17 ± 0.03b 102.5 ± 28.3d 52.8 ± 9.2b 36.28 ± 7.27c 1.04 ± 0.35d
NC- Normal control, DC- Diabetic control, MIP-Morus indica leaves powder, INS-Insulin, GNB-Glibenclamide. n= 6 in each group.
Mean values carrying superscripts a, b, c and d in columns differ significantly (p<0.05) between groups.
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Figure 1: Lipid profile of the normal and streptozotocin induced
diabetic animals.
NC- Normal control, DC-Diabetic control, MIP-Morus indica leaves
powder, INS-Insulin, GNB-Glibenclamide.
islet cells (Taniguchi et al., 1998). It is known that insulin resistance
in type 2 diabetes is not confined only to glucose metabolism but
also covers fatty acid metabolism. The concurrent effect of Morus
indica therapy on fatty acid metabolism was significant in diabetic
animals, this was evidenced by the reduction of serum cholesterol,
triglycerides and lipid peroxides in animals treated with Morus
indica.
Compared to an earlier study reporting blood glucose lowering
effect at a level of 25% supplementation (Shukla et al., 2000) in the
present study, much lower levels of mulberry (500 mg/kg b.wt)
decreased blood glucose levels similar to the effect shown by
standard drugs.
Conclusion
Research on medicinal plants per se could provide useful leads
towards the development of newer alternatives for the treatment.
From this experimental data, it is evident that mulberry leaves
efficiently regulated blood glucose in diabetic rats, restored the
elevated activity of the carbohydrate metabolic enzymes and also
ameliorated lipid abnormalities associated with diabetes in STZ-
diabetic rats.
Acknowledgement
The first author thanks University Grant Commission (UGC),
India, for awarding the fellowship for pursuing the research work.
Conflict of interest
We declare that we have no conflict of interest.
References
Andallu, B.; Suryakantham, V.V.; Srikanthi, B.L.; Reddy, G.K. (2001).
Effect of mulberry (Morus Indica. L) therapy on plasma and
erythrocyte membrane lipids in patients with type-2 diabetes, Clin
Chem Acta., 314: 47-53.
Andallu, B.; Varadacharyulu, N.C. (2003). Antioxidant role of mulberry
(Morus Indica. .Cv. Anantha) leaves in streptozotocin-diabetic rats,
Clin Chem Acta., 338: 3-10.
Beutler, E.; Duron, O.; Kelly, B.M. (1963). Improved method for the
determination of blood Glutathione,   J Lab Clin Med., 61: 882-90.
Chandrashekar, B.; Mukherjee, B.; Mukherjee, S.K. (1989). Blood
sugar lowering potentiality of selected Cucurbitaceae plants of Indian
origin, Ind J Med Res., 300-305.
Grover, J.K.; Yadav, S.; Vats, V. (2002). Medicinal plants of India with
hypoglycemic potentials, J of Ethnopharm., 81:81-100.
Gupta, R.; Bajpai, K.G.; Johri, S.; Saxena, A.M. (2008). An overview
of Indian novel traditional medicinal plants with antidiabetic
potentials, Afr J Tradl, Comply, Altr med., 5(1): 1-17.
Kaleem, M.; Kirmani, D.; Asif, M.; Ahmed, Q.; Bano, B. (2006).
Biochemical effects of Nigella Sativa L seeds in diabetic rats, Ind. J
Exptl Biol., 44: 745-748.
Kameswararao, B.; Kesavulu, M.M.; Apparao, C. (2003). Evaluation
of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic
rats, Fitoterapia., 74: 7-13.
Kelkar, S.M.; Bapat, V.A.; Ganapathi, T.R.; Kaklij, G.S.; Rao, P.S.;
Heble, M.R. (1996). Determinations of hypoglycemic activity in
Morus Indica L. (Mulberry) shoot cultures, Cur Sci., 71: 71-72.
Khan, B.A.; Abraham, A.; Leelamma. (1995). Hypoglycemic action
of Murraya   koenigii (curry leaf) and Brassica juncea  (mustard):
Mechanism of action, Ind J Biochem Biophy, 32: 106-108.
Kim, J.S.; Ju, J.B.; Choi, C.W.; Kim, S.C. (2006). Hypoglycemic and
Antihyperlipidemic Effect of Four Korean Medicinal Plants in Alloxan
Induced Diabetic Rats, Amer J Biochem Biotech., 2 (4): 154-160.
Kumar, G.S.; Shetty, A.K.; Salimath, P.V. (2005). Modulatory effect
of fenugreek seed mucilage and Spent Turmeric on intestinal and
renal disaccharidases in streptozotocin induced diabetic rats, Plant fds
Human Nutr., 60: 87-91.
Mukherjee, P.K.; Maiti, K.; Mukherjee, K.; Houghton, P.J. (2006).
Leads from Indian medicinal plants with hypoglycemicpotentials, J
Ethnopharm., 106: 1-28.
Ohkawa, H.; Ohishi, N.; Yagi, K. (1979). Assay for lipid peroxides in
animal’s tissue by Thiobarbituric reaction, Anal Biochem., 95: 351-
358.
Ragavan, B.; Krishnakumari, S. (2006). Antidiabetic effect of T. Arjuna
bark extract in alloxan induced diabetic rats, Ind J Clin Biochem.,
21(2): 123-128.
Saxena, A.; Vikram, N.K. (2004). Role of selected Indian plants in the
management of type2 diabetes: a review, J  Altern Complem med.,
10: 369-378.
Sheela, C.G.; Augusti, K.T. (1992). Antidiabetic effects of S-allyl
cysteine sulphoxide isolated from garlic Allium sativum Linn, Ind J
Exptl Biol., 30(6): 523-526.
Shukla, R.; Sharma, S.B.; Puri, D.; Prabhu, K.M.; Murthy, P.S. (2000).
Medicinal plants for treatment of diabetes mellitus, Ind J  Clin
Biochem., 15(10): 169-177.
Srinivasan, K. (2005). Plant foods in the management of diabetes
mellitus: Spices as beneficial antidiabetic food adjuncts, Intl J Food Sci
Nutr., 56(6): 399-414.
Tanginuichi, S.; Asano, N.; Tomino, F.; Miwa, I. (1998). Potentiation
of glucose induced insulin secretion by fagomine, a pseudosugar isolated
from mulberry leaves, Horm Metb Res., 30: 679-683.
Vasanthamani, G.; Savitha, D. (2001). Hypoglycemic and
hypocholesterolemic effect of selected herbal powder, Ind J Nutr
Diet., 33: 419-427.
Venkatesh, S.; Reddy, G.D.; Reddy, B.M.; Ramesh, M.; Appa Rao,
A.V.N. (2003). Antihyperglycemic activity of Caralluma attenuate,
Fitoterapia., 74: 274-279.
Vishalakshi, D.; Urooj, A. (2008): Hypoglycemic potential of Morus
indica L and Costus igneus-A pilot study, Ind J Exptl Biol., 46: 614-
616.
